Endogenous prostaglandin endoperoxides may alter infarct size in the presence of thromboxane synthase inhibition: studies in a rabbit model of coronary artery occlusion-reperfusion.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Journal of the American College of Cardiology

• Publication date

  1993-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0735-1097(93)90694-VPMID 8426016
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Does antiplatelet therapy enhance myocardial salvage after coronary reperfusion?

  1990cited by this paper
• Prostaglandin redirection by thromboxane synthetase inhibition. Attenuation of myocardial stunning in canine heart.

  1990cited by this paper
• Endogenous prostaglandin endoperoxides and prostacyclin modulate the thrombolytic activity of tissue plasminogen activator. Effects of simultaneous inhibition of thromboxane A2 synthase and blockade of thromboxane A2/prostaglandin H2 receptors in a canine model of coronary thrombosis.

  1990cited by this paper
• Effect of the thromboxane A2 receptor antagonist SQ 30,741 on ultimate myocardial infarct size, reperfusion injury and coronary flow reserve.

  1989cited by this paper
• Specific Platelet Mediators and Unstable Coronary Artery Lesions: Experimental Evidence and Potential Clinical Implications

  1989cited by this paper
• R 68 070: Thromboxane A2 Synthetase Inhibition and Thromboxane A2/Prostaglandin Endoperoxide Receptor Blockade Combined in One Molecule - I. Biochemical Profile In Vitro

  1989cited by this paper
• Progressive impairment of regional myocardial perfusion after initial restoration of postischemic blood flow.

  1989cited by this paper
• R 68 070: Thromboxane A2 Synthetase Inhibition and Thromboxane A2/Prostaglandin Endoperoxide Receptor Blockade Combined in One Molecule - II. Pharmacological Effects In Vivo and Ex Vivo

  1989cited by this paper
• Nonsteroidal Antiinflammatory Drugs Aggravate Acute Myocardial Ischemia in the Perfused Rabbit Heart: A Role for Prostacyclin

  1988cited by this paper
• Effect of the Thromboxane Receptor Antagonist SQ 29,548 on Myocardial Infarct Size in Dogs

  1988cited by this paper
• Prostaglandin endoperoxides modulate the response to thromboxane synthase inhibition during coronary thrombosis.

  1988cited by this paper
• Reduction of experimental canine myocardial infarct size with prostaglandin E1: inhibition of neutrophil migration and activation.

  1988cited by this paper
• Reduction in infarct size by the prostacyclin analogue iloprost (ZK 36374) after experimental coronary artery occlusion-reperfusion.

  1988cited by this paper
• Thromboxane Synthetase Inhibitors Reduce Infarct Size by a Platelet‐Dependent, Aspirin‐Sensitive Mechanism

  1988cited by this paper
• Cardioprotective Actions of Specific Thromboxane Receptor Antagonist in Acute Myocardial Ischemia

  1987cited by this paper
• Thromboxane A2 biosynthesis in human disease.

  1987cited by this paper
• The effect of acute hypercholesterolemia on myocardial infarct size and the no-reflow phenomenon during coronary occlusion-reperfusion.

  1987cited by this paper
• Iloprost Inhibits Neutrophil Function In Vitro and In Vivo and Limits Experimental Infarct Size in Canine Heart

  1987cited by this paper
• Effects of a thromboxane synthetase inhibitor and a thromboxane antagonist on release and activity of thromboxane A2 and prostacyclin in vitro.

  1985cited by this paper
• Pharmacological actions of SQ 29,548, a novel selective thromboxane antagonist.

  1985cited by this paper
• Further evidence that thromboxane exacerbates arrhythmias: effects of UK38485 during coronary artery occlusion and reperfusion in anaesthetized greyhounds.

  1984cited by this paper
• Accumulation of Unesterified Arachidonic Acid in Ischemic Canine Myocardium: Relationship to a Phosphatidylcholine Deacylation‐Reacylation Cycle and the Depletion of Membrane Phospholipids

  1984cited by this paper
• The influence of selective thromboxane synthetase inhibition with a novel imidazole derivative, UK-38,485, on prostanoid formation in man.

  1983cited by this paper
• Prevention of extension of ischaemic damage following acute myocardial ischaemia by dazoxiben, a new thromboxane synthetase inhibitor.

  1983cited by this paper
• Protection of Ischemic Cat Myocardium By CGS‐13080, a Selective Potent Thromboxane A2 Synthesis Inhibitor

  1983cited by this paper
• Salvage of ischemic myocardium by prostacyclin during experimental myocardial infarction.

  1983cited by this paper
• Platelet-mediated vascular contractions. Inhibition by flunarizine, a calcium-entry blocker.

  1983cited by this paper
• Platelet-mediated vascular contractions. Inhibition by flunarizine, a calcium-entry blocker.

  1983cited by this paper
• A thromboxane synthetase inhibitor reorients endoperoxide metabolism in whole blood towards prostacyclin and prostaglandin E2.

  1982cited by this paper
• Inhibition of platelet thromboxane synthesis by 7-(1-imidazolyl) heptanoic acid: dissociation from inhibition of aggregation.

  1981cited by this paper
• Early phase acute myocardial infarct size quantification: validation of the triphenyl tetrazolium chloride tissue enzyme staining technique.

  1981cited by this paper
• Influence of sulfinpyrazone and naproxen on infarct size in the dog.

  1981cited by this paper
• Thromboxane and prostacyclin release from ischaemic myocardium in relation to arrhythmias

  1981cited by this paper
• Lack of effect of aspirin on myocardial infarct size in the dog.

  1981cited by this paper
• Role of Prostacyclin in the Preservation of Ischemic Myocardial Tissue in the Perfused Cat Heart

  1980cited by this paper
• Autoradiographic method for measuring the ischemic myocardium at risk: effects of verapamil on infarct size aftr experimental coronary artery occlusion.

  1980cited by this paper
• Blood levels of 6-oxo-prostaglandin F 1 alpha during endotoxin-induced hypotension in rabbits.

  1980cited by this paper
• Blood levels of 6-oxo-prostaglandin F1α during endotoxin-induced hypotension in rabbits

  1980cited by this paper
• Influence of thromboxane inhibition on the severity of myocardial ischemia in cats.

  1980cited by this paper
• Effects of prostaglandin F2alpha administration prior to coronary ligation.

  1978cited by this paper
• Imidazole: a selective inhibitor of thromboxane synthetase.

  1977cited by this paper
• Application of imidazole as a selective inhibitor thromboxane synthetase in human platelets.

  1977cited by this paper
• Influence of nonsteroidal anti-inflammatory agents on myocardial ischemia in the cat.

  1976cited by this paper
• Beneficial effects of prostaglandin F2α in experimental myocardial infarction

  1974cited by this paper
• Isolation and structure of two prostaglandin endoperoxides that cause platelet aggregation.

  1974cited by this paper
• The "no-reflow" phenomenon after temporary coronary occlusion in the dog.

  1974cited by this paper
• Total and Regional Coronary Blood Flow Measured by Radioactive Microspheres in Conscious and Anesthetized Dogs

  1969cited by this paper

• Cerebro-Cardiovascular Diseases

  2020cites this paper
• Roles of prostanoids in the pathogenesis of cardiovascular diseases: Novel insights from knockout mouse studies.

  2011cites this paper
• Evaluation of BM-573, a novel TXA2 synthase inhibitor and receptor antagonist, in a porcine model of myocardial ischemia-reperfusion.

  2006influential citation
• Randomized Trial of Ridogrel , a Combined Thromboxane A 2 Synthase Inhibitor and Thromboxane A 2 / Prostaglandin Endoperoxide Receptor Antagonist , Versus Aspirin as Adjunct to Thrombolysis in Patients With Acute Myocardial Infarction

  2005cites this paper
• The Arachidonic Acid Cascade: Thromboxane A2 Antagonism and Synthetase Inhibition in Experimental Myocardial Infarction

  2004cites this paper
• Comparison of Cardioprotective Efficacy of Two Thromboxane A2 Receptor Antagonists

  2003cites this paper
• NCX4016 (NO‐aspirin) reduces infarct size and suppresses arrhythmias following myocardial ischaemia/reperfusion in pigs

  2002cites this paper
• Roles of Prostaglandin I2 and Thromboxane A2 in Cardiac Ischemia-Reperfusion Injury: A Study Using Mice Lacking Their Respective Receptors

  2001cites this paper
• Effects of recombinant active site‐blocked activated factor VII in rabbit models of carotid stenosis and myocardial infarction

  2000cites this paper
• Recombinant human, active site-blocked factor VIIa reduces infarct size and no-reflow phenomenon in rabbits.

  2000cites this paper
• Nicotine-Induced Changes in Eicosanoid Synthesis in Man: Effects of Smoking Cessation, Nicotine Substitution, Pyridoxine and Nicotinic Acid

  2000cites this paper
• Reversible Thiol-Dependent Activation of Ryanodine-Sensitive Ca2+ Release Channel by Etoposide (VP-16) Phenoxyl Radical

  2000cites this paper
• AHEART May 47/5

  2000cites this paper
• Invasive lumeneröffnende Therapie

  1999cites this paper
• Cardiac Electrophysiological Effects of Platelet‐Derived Substances

  1999cites this paper
• The role of prophylactic fasciotomy and medical treatment in limb ischemia and revascularization.

  1998cites this paper
• Solute exchange in the rabbit myocardium: Ischaemia, reflow, and myocardial necrosis

  1998cites this paper
• New antithrombotic agents.

  1998cites this paper
• Invasive lumener??ffnende Therapie

  1998cites this paper
• Oxidative stress and Ca2+ transport in skeletal and cardiac sarcoplasmic reticulum

  1998cites this paper
• Oxidative Stress in Skeletal Muscle

  1998cites this paper
• Effects of tissue factor induced by oxygen free radicals on coronary flow during reperfusion

  1996cites this paper
• Platelet activation during myocardial ischaemia: a contributory arrhythmogenic mechanism.

  1996cites this paper
• Intimal injury in a transiently occluded coronary artery increases myocardial necrosis. Effect of aspirin

  1996cites this paper
• New antithrombotics.

  1995cites this paper
• Pathophysiology and related studies of the no reflow phenomenon in skeletal muscle.

  1995cites this paper
• Aurintricarboxylic Acid Reduces Platelet Deposition in Stenosed and Endothelially Injured Rabbit Carotid Arteries more Effectively than other Antiplatelet Interventions

  1995cites this paper
• Role of aspirin in modulating myocardial ischemic reperfusion injury

  1994cites this paper
• The pathophysiological role of platelets during myocardial ischaemia.

  1994cites this paper
• Randomized Trial of Ridogrel, a Combined Thromboxane A2 Synthase Inhibitor and Thromboxane A2/Prostaglandin Endoperoxide Receptor Antagonist, Versus Aspirin as Adjunct to Thrombolysis in Patients With Acute Myocardial Infarction: The Ridogrel Versus Aspirin Patency Trial (RAPT)

  1994cites this paper
• Prospective evaluation of a prostacyclin-sparing aspirin formulation and heparin/warfarin in aspirin users with unstable angina or non-Q wave myocardial infarction at rest. The Antithrombotic Therapy in Acute Coronary Syndromes Research Group.

  1994cites this paper
• Ridogrel does not increase the speed and rate of coronary recanalization in patients with myocardial infarction treated with alteplase and heparin.

  1994cites this paper